Baxter International Inc. (NYSE:BAX) Receives Average Rating of “Hold” from Analysts

Baxter International Inc. (NYSE:BAX) has been given a consensus rating of “Hold” by the thirteen research firms that are presently covering the company, MarketBeat reports. Two investment analysts have rated the stock with a sell rating, nine have assigned a hold rating and two have issued a buy rating on the company. The average 12 month price objective among brokers that have updated their coverage on the stock in the last year is $22.36.

A number of equities research analysts have recently commented on the company. The Goldman Sachs Group lifted their price objective on Baxter International from $19.00 to $21.00 and gave the company a “neutral” rating in a research report on Wednesday, July 15th. Citigroup reduced their target price on Baxter International from $28.00 to $27.00 and set a “neutral” rating on the stock in a report on Monday. Weiss Ratings raised Baxter International from a “sell (d-)” rating to a “sell (d)” rating in a research note on Friday, July 31st. TD Cowen increased their target price on shares of Baxter International from $20.00 to $24.00 and gave the stock a “hold” rating in a research report on Monday, July 27th. Finally, Stifel Nicolaus lifted their price target on shares of Baxter International from $19.00 to $24.00 and gave the company a “hold” rating in a research report on Tuesday, July 28th.

Baxter International Trading Up 0.4%

NYSE BAX opened at $24.31 on Wednesday. The firm’s fifty day moving average price is $25.34 and its 200 day moving average price is $21.43. The company has a market capitalization of $12.57 billion, a price-to-earnings ratio of -11.74, a price-to-earnings-growth ratio of 3.66 and a beta of 0.65. The company has a debt-to-equity ratio of 1.39, a current ratio of 1.95 and a quick ratio of 1.32. Baxter International has a 12 month low of $15.73 and a 12 month high of $30.00.

Baxter International (NYSE:BAX) last announced its earnings results on Thursday, July 30th. The medical instruments supplier reported $0.56 earnings per share for the quarter, topping the consensus estimate of $0.37 by $0.19. The business had revenue of $2.96 billion during the quarter, compared to the consensus estimate of $2.80 billion. Baxter International had a negative net margin of 9.27% and a positive return on equity of 16.57%. The business’s quarterly revenue was up 5.3% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.59 earnings per share. Baxter International has set its FY 2026 guidance at 1.950-2.150 EPS. On average, sell-side analysts expect that Baxter International will post 2.04 earnings per share for the current fiscal year.

Baxter International Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Thursday, October 1st. Investors of record on Friday, August 28th were issued a dividend of $0.01 per share. This represents a $0.04 annualized dividend and a dividend yield of 0.2%. The ex-dividend date was Friday, August 28th. Baxter International’s dividend payout ratio (DPR) is presently -1.93%.

Institutional Trading of Baxter International

Several large investors have recently modified their holdings of BAX. Jones Financial Companies Lllp purchased a new position in Baxter International in the second quarter valued at about $26,000. CYBER HORNET ETFs LLC increased its position in shares of Baxter International by 52.4% in the 2nd quarter. CYBER HORNET ETFs LLC now owns 2,153 shares of the medical instruments supplier’s stock worth $46,000 after purchasing an additional 740 shares during the last quarter. Community Bank N.A. acquired a new stake in shares of Baxter International in the 2nd quarter valued at about $46,000. Versant Capital Management Inc raised its stake in Baxter International by 552.2% during the second quarter. Versant Capital Management Inc now owns 2,413 shares of the medical instruments supplier’s stock valued at $51,000 after buying an additional 2,043 shares in the last quarter. Finally, EFG International AG bought a new position in Baxter International during the 2nd quarter worth approximately $67,000. 90.19% of the stock is currently owned by institutional investors and hedge funds.

Baxter International Company Profile

Baxter International Inc is a global healthcare company that develops and markets products used in hospitals, outpatient facilities and other care settings. Its portfolio includes intravenous solutions and administration sets, infusion pumps, parenteral nutrition products, injectable medicines, surgical products and systems for medication preparation and delivery.

The company also provides products and technologies that support anesthesia, critical care, patient monitoring and other hospital workflows.